Trial Profile
Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Albendazole (Primary)
- Indications Ascariasis; Helminthiasis; Hookworm infections; Malaria
- Focus Therapeutic Use
- 15 Oct 2015 New source identified and integrated (ClinicalTrials.gov NCT01658774).
- 15 Oct 2015 New trial record